Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias?

V Cagno, ED Tseligka, ST Jones, C Tapparel - Viruses, 2019 - mdpi.com
Heparan sulfate proteoglycans (HSPG) are composed of unbranched, negatively charged
heparan sulfate (HS) polysaccharides attached to a variety of cell surface or extracellular …

Nanoparticles as potential new generation broad spectrum antimicrobial agents

CS Yah, GS Simate - DARU Journal of Pharmaceutical Sciences, 2015 - Springer
The rapid emergence of antimicrobial resistant strains to conventional antimicrobial agents
has complicated and prolonged infection treatment and increased mortality risk globally …

Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection

XX Yang, CM Li, CZ Huang - Nanoscale, 2016 - pubs.rsc.org
Interactions between nanoparticles and viruses have attracted increasing attention due to
the antiviral activity of nanoparticles and the resulting possibility to be employed as …

Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict …

T Furubayashi, D Inoue, N Nishiyama, A Tanaka… - Pharmaceutics, 2020 - mdpi.com
Recently, various types of cultured cells have been used to research the mechanisms of
transport and metabolism of drugs. Although many studies using cultured cell systems have …

Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection

O Tavassoly, F Safavi, I Tavassoly - Molecular pharmacology, 2020 - ASPET
Heparan sulfate proteoglycans (HSPGs) are cell surface receptors that are involved in the
cellular uptake of pathologic amyloid proteins and viruses, including the novel coronavirus; …

Respiratory syncytial virus: prospects for new and emerging therapeutics

PA Jorquera, RA Tripp - Expert review of respiratory medicine, 2017 - Taylor & Francis
Introduction: Respiratory syncytial virus (RSV) is the major cause of lower respiratory tract
infections (LRTI) in infants, the elderly, and the immunocompromised. Although the …

Antimicrobial dendrimeric peptides: structure, activity and new therapeutic applications

MA Scorciapino, I Serra, G Manzo… - International journal of …, 2017 - mdpi.com
Microbial resistance to conventional antibiotics is one of the most outstanding medical and
scientific challenges of our times. Despite the recognised need for new anti-infective agents …

Preparation, characterization and in vitro antiviral activity evaluation of foscarnet-chitosan nanoparticles

E Russo, N Gaglianone, S Baldassari, B Parodi… - Colloids and Surfaces B …, 2014 - Elsevier
A new nanoparticulate system for foscarnet delivery was prepared and evaluated.
Nanoparticles were obtained by ionotropic gelation of chitosan induced by foscarnet itself …

[HTML][HTML] Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system

P Reus, H Guthmann, N Uhlig, M Agbaria… - Journal of Controlled …, 2023 - Elsevier
Despite tremendous global efforts since the beginning of the COVID-19 pandemic, still only
a limited number of prophylactic and therapeutic options are available. Although vaccination …

Inhibition of human metapneumovirus binding to heparan sulfate blocks infection in human lung cells and airway tissues

EM Klimyte, SE Smith, P Oreste, D Lembo… - Journal of …, 2016 - Am Soc Microbiol
Human metapneumovirus (HMPV), a recently discovered paramyxovirus, infects nearly
100% of the world population and causes severe respiratory disease in infants, the elderly …